Privacy Analytics > Resources > Events > Privacy + Security Academy’s Fall Forum
Privacy Regulation and Real-World Applications for Generative AI in Healthcare
Date of Event: October 24, 2024
Location: Washington, D.C.
Santa Borel, Associate Director, Data Privacy Solutions at Privacy Analytics will be moderating a panel discussion on Privacy Regulation and Real-World Applications for Generative AI in Healthcare. Guest panelists: Kelly Ko, Vice President, Innovation & Strategic Initiatives, Sharp HealthCare and Jiayan Chen, Partner, McDermott Will & Emery.
The panel discussion will explore privacy and governance considerations as they relate to Generative AI (GenAI), focusing on practical applications and exploring areas for improvements in healthcare. We will delve into specific uses of GenAI, based on the panelists’ experience, examining privacy and regulatory implications. Finally, we will look ahead, discussing proactive strategies for staying ahead of technological advancements and regulatory requirements.
Santa Borel helps clients maximize their investment in Privacy Analytics’ Eclipse Risk software platform in support of new product innovation, improved service delivery and business growth. Santa has led client engagements with Eclipse Risk since its first release. She delivers on-site technical workshops on data privacy and anonymization and provides on-going coaching within large client organizations in support of their strategic objectives around data use.
Santa Borel
Associate Director, Data Privacy Solutions
Situation: California’s Consumer Privacy Act inspired Comcast to evolve the way in which they protect the privacy of customers who consent to share personal information with them.
Situation: Integrate.ai’s AI-powered tech helps clients improve their online experience by sharing signals about website visitor intent. They wanted to ensure privacy remained fully protected within the machine learning / AI context that produces these signals.
Situation: Novartis’ digital transformation in drug R&D drives their need to maximize value from vast stores of clinical study data for critical internal research enabled by their data42 platform.
Situation: CancerLinQ™, a subsidiary of American Society of Clinical Oncology, is a rapid learning healthcare system that helps oncologists aggregate and analyze data on cancer patients to improve care. To achieve this goal, they must de-identify patient data provided by subscribing practices across the U.S.
Situation: Needed to ensure the primary market research process was fully compliant with internal policies and regulations such as GDPR.
Situation: Needed to enable AI-driven product innovation with a defensible governance program for the safe and responsible use
of voice-to-text data under Shrems II.
This course runs on the 2nd Wednesday of every month, at 11 a.m. ET (45 mins). Click the button to register and select the date that works best for you.